40 unknown. 40 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 40 | Unknown 40 |
Follow Hyperlipidemias: new trials by email Literature Review of Hyperlipidemias trials Research Report on Hyperlipidemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound Inclisiran - Carotid Plaque, Hyperlipidemia | Phase 4 | Unknown | First Affiliated Hospital of Xinjiang Medical University | 40 | 2024-09-20 | 2024-09-19 |
| Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes EPAVasc, Corn Oil - Diabetes Type 2, Hypertriglyceridemia | Phase 4 | Unknown | University of Ioannina | 450 | 2023-12-01 | 2023-11-15 |
| Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis insulin, standard treatment - Hypertriglyceridemia, Acute Pancreatitis | Phase 4 | Unknown | University Medical Centre Ljubljana | 30 | 2022-11-01 | 2022-11-01 |
| Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia Rosuvastatin 20, Rosuvamibe 10/10 - Left Ventricular Diastolic Dysfunction, Hyperlipidemias | Phase 4 | Unknown | Yonsei University | 200 | 2021-01-06 | 2021-01-15 |
| Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia Evolocumab, Ezetimibe, Placebo - Hypercholesterolemia, CKD Stage 5 | Phase 4 | Unknown | Policlinico Casilino ASL RMB | 50 | 2020-11-01 | 2020-12-17 |
| Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients Evolocumab, Placebo, Ezetimibe - Hypercholesterolemia, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Unknown | Policlinico Casilino ASL RMB | 50 | 2020-05-04 | 2020-05-26 |
| Effect of Atorvastatin on Carotid Intima Media Thickness Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment - Essential Hypertension, Hypercholesterolemia | Phase 4 | Unknown | Yerevan State Medical University | 200 | 2020-04-15 | 2020-03-13 |
| Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia Evolocumab Auto-Injector [Repatha], Placebos - Familial Dysbetalipoproteinemia, Hyperlipoproteinemia Type III | Phase 4 | Unknown | UMC Utrecht | 30 | 2019-08-01 | 2019-01-22 |
| Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population Simvastatin 40mg, Ezetimibe/simvastatin 10/20 mg/day, Ezetimibe/simvastatin 10/40 mg/day - Hypercholesterolemia, Chronic Kidney Diseases | Phase 4 | Unknown | Hue University of Medicine and Pharmacy | 30 | 2018-06-15 | 2019-08-13 |
| Pharmacokinetics of Simvastatin Post Laparoscopic Sleeve Gastrectomy (LSG) Simvastatin - Obesity, Hyperlipidemias | Phase 4 | Unknown | National University Hospital, Singapore | 10 | 2018-06-13 | 2022-04-08 |
| Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis. Insulin, plasmapheresis - Acute Pancreatitis, Hypertriglyceridemia | Phase 4 | Unknown | First Affiliated Hospital of Wenzhou Medical University | 200 | 2018-06-06 | 2018-06-06 |
| Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease Evolocumab 140 mg/mL Subcutaneous Injection 1 milliliter (mL) pre-filled injector Pen x 3 for a monthly dose of 420 mg for 6 months., Placebo 1milliliter (mL) Subcutaneous Injection pre-filled injector Pen x 3 monthly for 6 months. - Peripheral Arterial Disease | Phase 4 | Unknown | Leonardo Clavijo | 86 | 2017-12-14 | 2020-03-12 |
| Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis Insulin, Aphesis - Pancreatitis, Acute, Hypertriglyceridemia | Phase 4 | Unknown | Peking Union Medical College Hospital | 220 | 2017-11-01 | 2017-11-17 |
| Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab Alirocumab - Atherosclerosis, Hyperlipidemia | Phase 4 | Unknown | Westside Medical Associates of Los Angeles | 35 | 2016-11-01 | 2019-04-26 |
| Effect of Rosuvastatin Therapy on HDL2 Level Rosuvastatin 10mg/d group, Rosuvastatin 20mg/d group - Hyperlipemia, Coronary Heart Disease | Phase 4 | Unknown | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 300 | 2015-11-01 | 2015-11-03 |
| Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Rosuvastatin 5mg, Rosuvastatin 20mg - Coronary Artery Disease, Coronary Disease | Phase 4 | Unknown | Korea University Anam Hospital | 300 | 2015-09-01 | 2016-08-09 |
| Nutraceuticals to Improve Lipid Profile in European Countries Non-pharmacologic intervention, Nutraceuticals (Armolipid Plus) - Hyperlipidemia | Phase 4 | Unknown | University of Roma La Sapienza | 100 | 2014-01-01 | 2013-03-07 |
| Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome Fenofibrate, Simvastatin - Acute Coronary Syndrome, Diabetes Mellitus, Type 2 | Phase 4 | Unknown | Koval' O., MD | 60 | 2014-01-01 | 2016-08-04 |
| Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia Food supplement - Hypercholesterolemia | Phase 4 | Unknown | Meir Medical Center | 60 | 2013-05-01 | 2013-05-08 |
| Lovaza Mechanisms of Action Omega 3 fatty acid (Lovaza) - Moderate Hypertriglyceridemia. | Phase 4 | Unknown | Brigham and Women's Hospital | 40 | 2012-08-01 | 2013-02-25 |
Showing 20 of 40. Sign in to see all of them.
Hypercholesterolemia (17) · Hypertriglyceridemia (9) · Diabetes Mellitus (6) · Coronary Artery Disease (5) · Atherosclerosis (4) · Coronary Disease (4) · Diabetes Mellitus, Type 2 (4) · Hypertension (4) · Inflammation (3) · Pancreatitis (3) · Renal Insufficiency, Chronic (3) · Cardiovascular Diseases (2) · Dyslipidemias (2) · HIV Infections (2)
Lipid Metabolism Disorders (40) · Metabolic Diseases (40) · Nutritional and Metabolic Diseases (40) · Dyslipidemias (38) · Vascular Diseases (15) · Cardiovascular Diseases (14) · Pathological Conditions, Signs and Symptoms (11) · Glucose Metabolism Disorders (10) · Arterial Occlusive Diseases (9) · Arteriosclerosis (9) · Endocrine System Diseases (8) · Pathologic Processes (8) · Urogenital Diseases (8) · Heart Diseases (7)
Rosuvastatin Calcium (8) · Ezetimibe (5) · Simvastatin (5) · evolocumab (4) · Atorvastatin (3) · Fenofibrate (3) · Insulin (3) · Omacor (3) · Dietary Supplements (2) · Exercise (2) · Population Groups (2) · Pravastatin (2) · ALN-PCS (1) · Amlodipine (1) · Aspirin (1)
Policlinico Casilino ASL RMB (2) · University of Roma La Sapienza (2) · Abant Izzet Baysal University (1) · Azienda Ospedaliero Universitaria di Sassari (1) · Brigham and Women's Hospital (1) · Bronx VA Medical Center (1) · Chinese PLA General Hospital (1) · Danish HIV Research Group (1) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · First Affiliated Hospital of Wenzhou Medical University (1) · First Affiliated Hospital of Xinjiang Medical University (1) · Hanmi Pharmaceutical Company Limited (1) · Hospital Universitario Pedro Ernesto (1) · Hospital de Sabadell (1) · Hue University of Medicine and Pharmacy (1)
Italy (8) · United States (6) · South Korea (5) · China (3) · Japan (3) · Brazil (1) · Denmark (1) · Greece (1) · Israel (1) · Singapore (1) · Spain (1) · Turkey (Türkiye) (1) · Ukraine (1) · Vietnam (1)
Alex Laursen, M.D., DMSc (1) · Andrea E Satta, MD (1) · Angelo Branzi, MD (1) · Ann-Brit E Hansen, M.D. (1) · Asim Shabbir, MBBS (1) · Charles Glueck, MD (1) · Court Pedersen, Professor (1) · Dario Giugliano, MD,PhD (1) · Do-sun Lim, MD, PhD (1) · Duong Thi Ngoc Lan, Master (1) · Fernanda J Medeiros, PhD (1) · Francesco Pelliccia, MD (1) · Frank LJ Visseren, prof (1) · Hamayak Sisakian, MD (1)
PMID 38018702, PMID 17898099, PMID 18955731, PMID 22584085, PMID 22615342, PMID 23428644, PMID 24465490, PMID 24528685, PMID 24595147, PMID 24739590, PMID 24843697, PMID 25022285, PMID 25401325, PMID 27165949, PMID 28399815, PMID 28755807, PMID 30565155, PMID 31215460